Background: Branched actin filament networks driving cell motility, endocytosis, and intracellular transport are assembled in seconds by the Arp2/3 complex and must be equally rapidly debranched and turned over. One of the only factors known to promote debranching of actin networks is the yeast homolog of glia maturation factor (GMF), which is structurally related to the actin filament-severing protein cofilin. However, the identity of the molecular mechanism underlying debranching and whether this activity extends to mammalian GMF have remained open questions. Results: Using scanning mutagenesis and total internal reflection fluorescence microscopy, we show that GMF depends on two separate surfaces for debranching. One is analogous to the G-actin and F-actin binding site on cofilin, but we show using fluorescence anisotropy and chemical crosslinking that it instead interacts with actin-related proteins in the Arp2/3 complex. The other is analogous to a second F-actin binding site on cofilin, which in GMF appears to contact the first actin subunit in the daughter filament. We further show that GMF binds to the Arp2/3 complex with low nanomolar affinity and promotes the open conformation. Finally, we show that this debranching activity and mechanism are conserved for mammalian GMF. Conclusions: GMF debranches filaments by a mechanism related to cofilin-mediated severing, but in which GMF has evolved to target molecular junctions between actin-related proteins in the Arp2/3 complex and actin subunits in the daughter filament of the branch. This activity and mechanism are conserved in GMF homologs from evolutionarily distant species.
Introduction
The rapid assembly and disassembly of branched actin filament networks nucleated by the Arp2/3 complex is responsible for driving the locomotion of a wide variety of cellular structures [1] . The Arp2/3 complex is a seven-subunit assembly consisting of two actin-like proteins and five unrelated proteins [2, 3] . When bound to a nucleation-promoting factor (NPF) of the Wiskott-Aldrich Syndrome protein (WASp) superfamily, it is capable of nucleating a new actin filament [4] [5] [6] from the side of a preexisting mother filament [2] . Tomographic reconstructions of these branches show that the Arp2/3 complex is stably associated with junctions, positioned such that the two actin-like subunits, Arp2 and Arp3, anchor the pointed end of the daughter filament [7] . This mechanism of Arp2/3 complex nucleation has been known for some time; however, much less is known about branched network pruning and disassembly.
For continuous growth and force generation, branched actin networks must be turned over as rapidly as they are polymerized. The actin filament-severing protein cofilin/ADF (actindepolymerizing factor) plays one critical role in this process [8] [9] [10] . Cofilin binds cooperatively to actin filament sides and changes their twist by w5 [11] [12] [13] [14] . Severing occurs at the boundaries between cofilin-bound and unbound regions [15] . Cofilin also has been proposed to remove Arp2/3 complex branch junctions [16, 17] . However, evidence suggests that this effect occurs via cofilin targeting the mother filament and not the Arp2/3 complex itself [17] .
Cofilin is part of a larger superfamily of proteins called actindepolymerizing factor homology (ADFH) proteins, which also includes twinfilin, Abp1/drebrin, coactosin, and glia maturation factor (GMF) [18] . Although these other ADFH proteins have all been implicated in regulating actin cytoskeleton dynamics, their biochemical activities and genetic phenotypes are not as well understood as those of cofilin. GMF family proteins do not interact with actin but instead bind to the Arp2/3 complex [19] [20] [21] . In reconstitution experiments, GMF isoforms from yeast and mammals inhibit actin nucleation stimulated by the Arp2/3 complex and the VCA domain of WASp-family proteins [19, 21] . Remarkably, at much lower concentrations, yeast Gmf1/Aim7 [22] removes daughter filaments from their mothers without inducing severing events at other locations [19] . Thus, Gmf1 may sever at branch junctions. These observations have left many important questions unanswered: Is GMF's debranching mechanism related to cofilin's filament-severing mechanism? Is debranching a conserved function? How does GMF interact with the Arp2/3 complex?
To address these questions, we performed scanning mutagenesis of yeast Gmf1 to define surfaces important for its in vivo and biochemical functions. This analysis revealed that Arp2/3 complex binding and nucleation inhibition by GMF depend specifically on a surface that is analogous to the surface of cofilin that binds both actin monomer and filament, which we term ''site 1.'' Debranching requires an additional GMF surface that is analogous to a surface on cofilin that binds specifically to F-actin, which we term ''site 2'' [23] . We extended these analyses to mouse GMFg and determined that debranching is a conserved function. Furthermore, we found that a site 2 mutation in GMFg disrupts debranching without affecting inhibition of nucleation activity, just as was observed for this mutation in yeast Gmf1. A combination of biophysical, modeling, and biochemical methods suggests that GMF prunes daughter filaments by a cofilin-related severing mechanism in which GMF uses site 1 to bind to actin-related proteins (Arps) in the Arp2/3 complex and site 2 to bind the first actin subunit in the daughter filament.
Results

Site-Directed Mutagenesis of Gmf1
To dissect GMF function, we generated six gmf1 alleles based on homology to cof1 alleles that have strong defects in cell growth and actin binding. Subsequently, we generated an additional 11 alleles that target clusters of charged or strongly conserved residues in GMF. Thus, in total we mutated 38 residues on Gmf1 within 17 different alleles ( Figure 1A ; see also Table S1 available online) .
In yeast, deletion of GMF1 exacerbates the growth defects of a cof1-22 mutant, lowering the restrictive temperature from 37 C to 34 C. Expressing Gmf1 under the GMF1 promoter (from a low-copy plasmid) in the cof1-22 gmf1D strain accelerates growth at 34 C (Figure 1 ). By expressing our Gmf1 mutants instead of wild-type, we identified six mutants that grew significantly slower than a strain carrying wild-type GMF1 ( Figure 1B ; Table S1 ). The mutated residues cluster in three distinct regions of the protein ( Figure 1C ). The first region, targeted by gmf1-17 (p = 0.03) and gmf1-20 (p < 0.01), corresponds to the same surface as site 1 of Cof1 [8] ( Figures 1D and S1 ). The second region, targeted by gmf1-101 (p < 0.01) and gmf1-16 (p < 0.01), corresponds to the same surface as site 2 ( Figures 1D and S1 ). The third region, targeted by gmf1-103, resides on a surface-exposed b strand adjacent to gmf1-101 and is not part of either site.
Debranching Activities of Mutant Gmf1 Proteins
To better understand the activities that underlie GMF1 cellular functions, we purified the mutant Gmf1 proteins that showed defects in vivo. The mutant Gmf1-103 could not be purified; thus, the growth defect may arise from a folding problem. The folding stabilities of other Gmf1 mutant proteins were similar to wild-type Gmf1, except for Gmf1-17 and Gmf1-16. These had about 8 C lower and 5 C lower denaturation midpoint temperatures (T m ), respectively ( Figure S2 ). Note that these T m values are w20 C higher than the growth temperature, and thus the proteins are most likely stable in vivo.
We compared the debranching activity of these Gmf1 proteins using real-time total internal reflection fluorescence (TIRF) microscopy analysis of actin filament dynamics nucleated by yeast Arp2/3 complex and WASp VCA [19] . In reactions lacking Gmf1, branched filaments were rapidly nucleated, and debranching events were rare (Figure 2A . We then performed this analysis in the presence of 20 nM Gmf1 or a mutant variant ( Figure 2B ). At this concentration, debranching is readily detectable and subsaturating [19] , making the assay sensitive to differences in K i . As shown previously [19] ). In addition to the mutants above, we purified Gmf1-4, which is a serine-to-glutamate substitution, as it targets a site reported to be phosphorylated in mammalian GMF [20] . We also purified Gmf1-105, because it targets a patch of acidic residues proximal to Gmf1-103. Gmf1-4 debranched as efficiently as wild-type Gmf1 ( Figure 2C ; Inhibition of Nucleation by Arp2/3 Complex Depends on Site 1 of Gmf1 At higher concentrations, Gmf1 also binds to Arp2/3 complex in solution and inhibits Arp2/3 complex-mediated nucleation [19] [20] [21] . Therefore, we tested the mutant Gmf1 proteins for inhibition of nucleation by Arp2/3 complex. Wild-type Gmf1 robustly inhibited Arp2/3 complex-mediated nucleation (Figures 3A and 3B ), whereas mutant Gmf1 proteins exhibited variable defects ( Figure 3B ; Table S2 ). Gmf1-20 and Gmf1-17, both of which target site 1, were defective in Arp2/3 complex inhibition (note that Gmf1-17 and Gmf1-20 saturate at different degrees of inhibition; see Discussion). In contrast, Gmf1-16 and Gmf1-101, both of which target site 2, were not significantly impaired in Arp2/3 complex inhibition.
The results show that residues in site 1 are important for inhibition of nucleation by Arp2/3 complex. In contrast, site 2 does not appear to be important for inhibition of nucleation by Arp2/3 complex ( Figure 3B ), but it is critical for debranching ( Figure 2C ). Thus, Gmf1-101 uncouples debranching from Arp2/3 complex nucleation inhibition and suggests that debranching requires additional molecular interactions (see Discussion). Curiously, our two pseudo-wild-type mutants (Gmf1-4 and Gmf1-105) were strongly defective in nucleation inhibition (Table S2 ). This suggests that nucleation inhibition is not strongly correlated with in vivo defects and therefore that debranching may be the more important activity in yeast cells. Interestingly, Gmf1-16 showed no defects in nucleation inhibition or debranching despite causing strong defects in vivo (Figure 1 ), suggesting that this surface on Gmf1 may contribute to regulation and/or localization in vivo. Indeed, the analogous Cof1-16 site is implicated in PIP2 binding [25] .
The mechanism of nucleation by Arp2/3 complex involves a number of steps, including a conformational change that brings the two Arp subunits into close proximity (known as the ''closed'' conformation) [26] . We used negative-stain electron microscopy (EM) to directly image Gmf1-GFP-bound Arp2/3 complex. Individual Arp2/3 complex particles were picked and classified ( Figure 3C ). The class sums were used to determine the fraction of Arp2/3 complexes in three conformations ( Figure 3D Figure 3D ). This is consistent with Gmf1 shifting the conformational distribution of Arp2/3 complex away from the closed and toward the open structure (chi-square test, p < 0.01).
Mouse GMFg Inhibits Nucleation by Arp2/3 Complex and Promotes Debranching
Debranching activity has thus far been demonstrated only for yeast Gmf1. We therefore performed debranching assays using bovine Arp2/3 complex and purified Mus musculus GMFg [20, 21] . This analysis revealed that GMFg indeed stimulates debranching ( Figure 4A ), although it was less active than yeast Gmf1. We then introduced an alanine substitution in GMFg at three residues (R19A K20A K22A), corresponding to the yeast Gmf1-101 ( Figure 1A ) allele that was defective specifically in debranching. GMFg-101 strongly abrogated debranching activity (Figure 4A) , demonstrating a mechanistic parallel between yeast and mouse GMFs.
We further compared the abilities of wild-type GMFg and mutant GMFg-101 to inhibit Arp2/3 complex-mediated nucleation. GMFg and GMFg-101 inhibited actin assembly by bovine Arp2/3 complex equally well ( Figure 4B ). Therefore, mouse GMFg-101 exhibits properties similar to those of its yeast counterpart: it is strongly impaired in debranching but shows normal nucleation inhibition activity. Remarkably, mouse GMFg could inhibit yeast Arp2/3 complex ( Figure 4C ), providing further evidence that the nature of the interactions between Arp2/3 complex and GMF is conserved across phylogenetic kingdoms.
Binding of Gmf1 to Arp2/3 Complex Our finding that Gmf1 site 1 is critical for the debranching and nucleation inhibition functions points to a possible interaction between Gmf1 and one or both Arp subunits in the Arp2/3 complex (Arp2 and/or Arp3). Indeed, in cofilin, site 1 binds to actin in a cleft between subdomains I and III [27] , a region highly conserved among actin, Arp2, and Arp3 [28] .
To determine the stoichiometry of Gmf1-Arp2/3 complex interactions, we performed multisignal sedimentation velocity analytical ultracentrifugation [29] . Here, sedimentation was followed using Raleigh interference signals and absorbance at 492 nm. Gmf1 was tagged with GFP (referred to as Gmf1-GFP) [19] , providing a unique signal at 492 nm. From sedimentation velocity data for these two signals ( Figure S3 ), diffusiondeconvoluted sedimentation coefficient distributions, c(s), were constructed for yeast Arp2/3 complex and Gmf1-GFP separately ( Figure 5A ). Free yeast Arp2/3 complex showed a sedimentation coefficient of 9.4S (Table S3) , similar to the 9.2S sedimentation coefficient reported for bovine Arp2/3 complex [30] . Free Gmf1-GFP sediments substantially more slowly than Arp2/3 complex ( Figure 5A ), consistent with it being present as a monomeric species. Similar experiments were performed for mixtures of Gmf1-GFP and Arp2/3 complex ( Figures S3D and S3E) , and multicomponent spectrally and diffusion-deconvoluted sedimentation coefficient distributions, c k (s), were fit for Arp2/3 complex and Gmf1-GFP ( Figure 5B ). These distributions show that Arp2/3 complex sediments more rapidly in the presence of Gmf1-GFP (Figure 5B ; Table S3 ), and that a portion of Gmf1-GFP cosediments with Arp2/3 complex.
By optimizing the ratio of Gmf1-GFP that cosediments with Arp2/3 complex in fitting ( Figures S3F and S3G) , we estimated the stoichiometry of Gmf1-GFP association with Arp2/3 complex. This was performed for a range of Gmf1-GFP concentrations in the presence of approximately 700 nM Arp2/3 complex. The observed stoichiometries (Table S3 ; Figure S3J ) indicate two binding sites for Gmf1 on Arp2/3 complex. In particular, a stoichiometry of two Gmf1-GFPs per Arp2/3 complex is seen when 3.5 mM unbound Gmf1-GFP is present. Substoichiometric concentrations of Gmf1-GFP bound Arp2/3 complex completely, consistent with the first binding site having a K D tighter than 30 nM ( Figure S3H ). At high Gmf1-GFP concentrations, additional bound and free Gmf1-GFP is observed ( Figure 5B ), consistent with a second, lower-affinity binding site. Assuming two asymmetric binding sites for GMF on Arp2/3 complex and using isotherms from effective particle theory [31] , the K D of the second Gmf1-GFP binding site is estimated to be w2 mM (Figures S3I and S3J ; Table S3 ).
Next, we measured the Arp2/3 complex binding affinities of selected Gmf1 mutants using the fluorescence anisotropy of Gmf1-GFP in the presence of yeast Arp2/3 complex. Gmf1-GFP bound to Arp2/3 complex with a K D of 13 6 2 nM (Figure 5C ). This is consistent with the high-affinity association revealed by analytical ultracentrifugation.
We then compared the abilities of untagged wild-type and mutant Gmf1 proteins to compete with Gmf1-GFP for binding Arp2/3 complex by monitoring the decrease in anisotropy of Gmf1-GFP. Competition with wild-type unlabeled Gmf1 demonstrated that it bound about as strongly as Gmf1-GFP, (D) Analysis of relative frequencies of Arp2/3 complex conformations with and without Gmf1-GFP. Particles were counted regardless of whether Gmf1-GFP could be seen bound to Arp2/3 complex. Excluding those particles that could not be assigned to a class, 3,758 particles were scored for Arp2/3 alone, and 5,584 were scored for Gmf1-GFP mixed with Arp2/3.
with a K D of 10 6 3 nM ( Figure 5D ; Table S2 ). Gmf1-16 (11 6 3 nM) and Gmf1-101 (10 6 3 nM) were unaffected in their ability to bind Arp2/3 complex ( Figure 5D ; Table S2 ), suggesting that site 2 does not play a role in directly binding Arp2/3 complex. Conversely, Gmf1-20 (210 6 50 nM) was strongly defective in binding ( Figure 5D ; Table S2 ). However, Gmf1-17, also in site 1 and defective in Arp2/3 inhibition, bound about as strongly as wild-type (10 6 4 nM; Figure 5D ; Table S2 ) (see Discussion).
Gmf1 Interacts with Arp2, Arp3, and Arc40 Subunits of Arp2/3 Complex
To identify Arp2/3 complex subunits (Arcs) directly contacting or in close proximity to GMF, we chemically crosslinked Gmf1 to Arp2/3 complex. Crosslinking between Arp2/3 complex subunits was prevented by decorating Gmf1 with N-hydroxysulfosuccinimide (sulfo-NHS) before mixing with Arp2/3 complex. A number of new bands were observed that were missing from an unreacted sample of Arp2/3 complex alone, unmodified Gmf1 alone, decorated Gmf1 alone, and Arp2/3 complex mixed with unmodified Gmf1 (Figure 6A ). Blotting with aGmf1 antibodies revealed several new, high-molecular-weight (MW) bands of discrete sizes, consistent with crosslinking to the larger subunits of Arp2/3 complex ( Figure 6B ). Comparison of silver-stained intensity of reacted and unreacted samples of Arp2/3 complex showed that the unmodified Arp3 and ArpC1/ Arc40 bands have detectable decreases in intensity. Blotting with aArp3 ( Figure 6C ), aArp2 ( Figure 6D ), and aArc40 (Figure 6E) showed that the new higher-MW bands contained each of these proteins. In contrast, very little crosslinking was apparent when blotting with aArc35 ( Figure 6F ). The remaining Arp2/3 complex subunits did not show detectable decreases in intensity and were not further explored. From these data, we conclude that there are GMF binding sites on, or proximal to, Arp2, Arp3, and Arc40. Intriguingly, these subunits are the same ones that bind VCA [30, [33] [34] [35] , and we observed that VCA can compete with GMF for binding to Arp2/3 complex in a fluorescence anisotropy-based assay ( Figure S4 ). These results are also consistent with competitive Arp2/3 complex binding observed between Schizosaccharomyces pombe VCA and GMF [21] .
Discussion
To address the mechanistic and structural basis for GMF's effects, we have performed a biochemical characterization, which leads to a model for its mechanism and interaction with both free Arp2/3 complex and Arp2/3 complex in the context of a filament branch junction. Although our study focused on yeast Gmf1, we extended the key findings to mammalian GMF homologs. This suggests that these Arp2/3 complex regulatory functions and mechanisms are widely conserved. Below, we consider each of these conclusions.
GMF Site 1 Interacts with the Arp2/3 Complex and Mediates Nucleation Inhibition
Our model for GMF interaction with the Arp2/3 complex is highly informed by previous work on cofilin. The two actin binding sites allow each cofilin molecule to bind two adjacent subunits in an actin filament [12-14, 17, 36] . These interactions lead to severing and creation of ends that accelerate disassembly [10, 37] . Cofilin also uses site 1 to bind G-actin (at the barbed end of the monomer) and inhibit nucleotide exchange [27, 38, 39] .
Two of our Gmf1 mutants (Gmf1-17 and Gmf1-20) were designed to mimic mutations in site 1 that disrupted cofilin binding to G-actin (Figures 1 and S1 ) [23] . Both of these mutants disrupted the ability of Gmf1 to inhibit nucleation by Arp2/3 complex in solution (Figure 3 ). Because Gmf1 binds strongly to Arp2/3 complex ( Figure 5 ; K D 10-13 nM) but lacks detectable affinity for monomeric actin ( [19] ; S.B.P., unpublished data), these results suggest that Gmf1 inhibits nucleation by binding to the Arp subunits Arp2 and/or Arp3 in a manner similar to how cofilin interacts with G-actin. Consistent with this view, Gmf1-20 was defective in binding Arp2/3 complex when measured by fluorescence anisotropy ( Figure 5 ). Gmf1-17 was not impaired in binding to Arp2/3 complex (Table  S2 ), suggesting that this less-conserved part of the site 1 is not essential for the interaction ( Figure 5 ) or does not affect the binding site reported on by the fluorescence anisotropy assay. Surprisingly, Gmf1-17 and Gmf1-20 also appear to affect nucleation inhibition in two different ways ( Figure 3B ), Gmf1-17 by altering the K i of the Arp2/3 complex-Gmf1 interaction, and Gmf1-20 by changing the activity level at saturation. However, our crosslinking data show that Gmf1 interacts with both Arp2 and Arp3 (Figure 6 ), and our analytical ultracentrifugation data reveal that there may be two Gmf1 binding sites on the Arp2/3 complex ( Figure 5 ). The specific defects observed for Gmf1-20 and Gmf1-17 in nucleation inhibition may therefore reflect altered interactions with two qualitatively distinct binding sites on the Arp2/3 complex, which differentially contribute to nucleation inhibition. Although this explanation is plausible, there are too many model parameters to allow quantitative interpretation of these surprising results at this time.
Despite these uncertainties, a qualitative structural mechanism for inhibition of nucleation by GMF can be inferred by using known structures to impose the analogy of the cofilin site 1 interaction with actin on the GMF interaction with Arp2 or Arp3. We constructed molecular models of this interaction by docking the GMFg structure onto the structure of bovine Arp2/3 structure [28] , using the structure of the twinfilin-actin complex [27] as a guide for positioning GMFg on the barbed ends of Arp2 and/or Arp3 (Figure 7) . We constructed several versions of the model, including GMF bound to Arp3 or Arp2 in the inactive conformation of the Arp2/3 complex [28, 40] . When GMF is engaged with Arp3 ( Figure 7A) , there are no additional contacts; when engaged with Arp2, GMF is also in contact with ArpC1/Arc40 ( Figure 7B ). GMF may bind to both sites at higher concentrations, explaining why both interactions were detected in our crosslinking experiments ( Figure 6 ). There are no major clashes in either of these models, with the exception of a few residues in the Arp3 cleft, which could presumably reposition upon GMF binding. Therefore, this model is consistent with our scanning mutagenesis, crosslinking, and analytical ultracentrifugation data.
How does GMF binding inhibit nucleation? Gmf1 appears to bind to the same subunits in the Arp2/3 complex as VCA, and it can be competed off of the Arp2/3 complex by the addition of VCA ( Figure S4 ). Thus, GMF may inhibit nucleation by interfering with NPF effects on the Arp2/3 complex. Furthermore, our EM data suggest that GMF alters the Arp2/3 complex conformation, shifting the distribution of particles from the closed to the open conformation ( Figure 3 ). This is similar to the proposed mechanism of Arp2/3 complex inhibition by coronin [26] .
GMF Site 2 Is Required Specifically for Debranching
If Gmf1 uses site 1 to interact with the barbed end of Arp2 or Arp3, as we have modeled (Figure 7) , then its site 2 would interact with the first actin subunit of the daughter filament, which forms a long-pitch dimer with one of the Arps. We modeled the interaction of GMF site 2 with the first actin Crosslinking analysis of sulfo-NHS-decorated Gmf1 and yeast Arp2/3 complex. Components were mixed as indicated at the top of each lane. Lanes with the same components added are from the same crosslinking sample but separate gels. Samples were separated by SDS-PAGE and either silver stained (A) or analyzed by western blotting with aGmf1 (B), aArp3 (C), aArp2 (D), aArpC1/Arc40 (E), or aArpC2/Arc35 (F) antibodies. Gmf1 self-crosslinking products are indicated in the anti-Gmf1 blot with ''xg.'' Gmf1-Arp2/3 crosslinking products are indicated with ''xl'' and a bracket. A portion of Arc40 runs anomalously [32] ; one of these bands is indicated by ''#.'' Silver-stain band intensity that decreased in the crosslinked sample is indicated by ''*.'' See also Figure S4 .
subunits of the daughter filament using the EM structure of cofilin-decorated actin filaments as a guide [13] ( Figures  7D and 7E) . This model is supported by our scanning mutagenesis results. Gmf1-101 lies in a surface that overlaps with the cofilin mutant Cof1-6, which impairs F-actin but not G-actin binding [41] . This contact was also highlighted as being critical to cofilin-F-actin interactions in a molecular dynamics simulation [36] . Gmf1-101 was severely defective in debranching but had a near wild-type ability to inhibit nucleation by Arp2/3 complex ( Figure 3 ) and showed normal binding to Arp2/3 complex in solution ( Figure 5 ). These observations support our structural model, which predicts that the surface perturbed by Gmf1-101 is positioned away from Arp2/3 complex ( Figure 7 ) and in contact with the first daughter actin ( Figures  7D and 7E) .
In sum, our model proposes that GMF debranches filaments through separate interactions with Arp3 and/or Arp2, mediated by site 1, and through interactions with actin mediated by site 2 ( Figure 7F ). The mechanism of debranching therefore appears to be related to actin severing by cofilin. Cofilin binding to filaments stabilizes a conformation in which actin subdomain 2 is partially displaced from the adjacent subunit, which may lead to severing [13] . Similarly in our model, GMF binding to the Arp2/3 complex at a branch junction requires partial displacement of subdomain 2 of the daughter filament actins from Arp2 and Arp3. Thus, GMF may stabilize a structure with weakened daughter filament-Arp2/3 complex interactions, leading to dissociation of the daughter filament.
A final point to consider is that while GMF is a dedicated debranching factor that does not sever filaments at other locations, ultimately its functions must be considered alongside those of cofilin. Cofilin binds cooperatively to filament sides and induces severing events at the boundaries of cofilin-decorated and bare regions, leading to filament fragmentation [10, 15, 37] . At higher saturation, this decoration also appears to disrupt Arp2/3 complex binding, inducing debranching. In the cellular context, it seems likely that both factors contribute to debranching [16, 17] . An important future goal will be to determine how GMF and cofilin influence each other and function together to regulate actin filament debranching and severing.
Experimental Procedures
Detailed strain construction, protein purification, and analysis methods can be found in the Supplemental Experimental Procedures.
Growth Curves pRS416-based plasmids carrying GMF1 alleles were transformed into cof1-22 gmf1D. Strains were inoculated at low density in 200 ml of synthetic media lacking uracil [42] in 96-well plates and grown with agitation in a multiwell plate reader (Tecan Group) at 34 C. Calculation of growth rates is described in the Supplemental Experimental Procedures.
TIRF Microscopy Debranching Assays
TIRF reactions were performed as described [43] and contained 1 mM rabbit skeletal muscle actin (10% Oregon green labeled), 10 nM yeast or bovine Arp2/3 complex, 100 nM dimeric VCA, and 20 nM wild-type or mutant Gmf1 as indicated. Detailed methods can be found in the Supplemental Experimental Procedures.
Actin Assembly Assays
Actin assembly assays using pyrene fluorescence were performed essentially as described previously [43] using freshly gel-filtered rabbit skeletal muscle actin and other proteins as indicated. In Figure 3 , pyrene signal was monitored in a multiwell plate reader (Tecan Group) set to excitation wavelength 365 nm and emission wavelength 407 nm. Experiments in Figure 4 were monitored in a fluorescence spectrophotometer (Photon Technologies International). Time to achieve one-half of the change in pyrene signal was determined by simple interpolation.
Fluorescence Anisotropy Measurements
A total of 4 nM of Gmf1-GFP was mixed with various concentrations of yeast Arp2/3 complex in 50 mM KCl, 10 mM imidazole (pH 7.0), 1 mM MgCl 2 , 1 mM EGTA, 0.5 mM DTT, and 0.1 mM ATP, incubated at room temperature for 15 min prior to measuring the fluorescence anisotropy of GMF by measuring polarized emission intensities at 510 nm when excited at 492 nm.
Analytical Ultracentrifugation
Analytical ultracentrifugation experiments were performed in an Optima XL-I centrifuge equipped with an An50-Ti rotor (Beckman Coulter). Individual sample components were gel filtered into 5 mM HEPES (pH 7.0), 50 mM KCl, 1 mM MgCl 2 , 1 mM EGTA, and appropriate volumes were combined without concentration, diluting with additional buffer and one-tenth volume of the same buffer supplemented with 1 mM ATP (final ATP concentration was 100 mM). Roughly 400 ml of each sample was placed in charcoal-filled, dual-sector Epon centerpieces and allowed to equilibrate at the experimental temperature (20 C) for several hours. Absorbance at 492 nm and Rayleigh interference were monitored as the proteins sedimented at a rotor speed of 42,000 rpm. c k (s) distributions were fit to the data using SEDPHAT [29, 44, 45] .
Electron Microscopy
Single-particle EM was performed essentially as described [46] , with some modifications. Full details can be found in the Supplemental Experimental Procedures.
Chemical Crosslinking Analysis
Gmf1 was purified to the SOURCE15Q ion exchange step, and 1 ml of 20 mM Gmf1 was then sulfo-NHS labeled on carboxylic acids using a two-step protocol [47] and gel filtered into XLB (10 mM HEPES [pH 7], 1 mM MgCl 2 , and 50 mM KCl). A total of 200 nM Arp2/3 complex was crosslinked to 2 mM Gmf1 for 4 hr; the crosslinking reactions were quenched with 50 mM glycine (pH 9.0). Samples were resolved by SDS-PAGE and imaged by silver staining or transferred to polyvinylidene fluoride and imaged by western blot. Western blotting was performed using anti-Arp3 (y-152; Santa Cruz Biotechnology), anti-Arp2 (yN-16; Santa Cruz Biotechnology), aArc40 [48] , aArc35 [49] , or aGmf1 [19] primary antibodies.
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